ArticleMovement disorders clinical practice2025

Miglustat as Disease-Modifying Therapy in a Patient with SCARB2-Related Action Myoclonus Renal Failure.

Fabiana Colucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.